Schmitz-Hubsch T, du Montcel ST, Baliko L, Berciano J, Boesch S, Depondt C, Giunti P, Globas C, Infante J, Kang JS, Kremer B, Mariotti C, Melegh B, Pandolfo M, Rakowicz M, Ribai P, Rola R, Schols L, Szymanski S, van de Warrenburg BP, Durr A, Klockgether T, Fancellu R. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology. 2006;66:1717–20. https://doi.org/10.1212/01.wnl.0000219042.60538.92.

Article  CAS  PubMed  Google Scholar 

Trouillas P, Takayanagi T, Hallett M, Currier RD, Subramony SH, Wessel K, Bryer A, Diener HC, Massaquoi S, Gomez CM, Coutinho P, Ben Hamida M, Campanella G, Filla A, Schut L, Timann D, Honnorat J, Nighoghossian N, Manyam B, The Ataxia Neuropharmacology Committee of the World Federation of Neurology. International cooperative ataxia rating scale for pharmacological assessment of the cerebellar syndrome. J Neurol Sci. 1997;145:205–11. https://doi.org/10.1016/s0022-510x(96)00231-6.

Article  CAS  PubMed  Google Scholar 

Shaikh AG, Kim JS, Froment C, Koo YJ, Dupre N, Hadjivassiliou M, Honnorat J, Kothari S, Mitoma H, Rodrigue X, Soong BW, Subramony SH, Strupp M, Schmahmann J, Manto M. Scale for ocular motor disorders in ataxia (SODA). J Neurol Sci. 2022;443: 120472. https://doi.org/10.1016/j.jns.2022.120472.

Article  PubMed  Google Scholar 

Garces P, Antoniades CA, Sobanska A, Kovacs N, Ying SH, Gupta AS, Perlman S, Szmulewicz DJ, Pane C, Nemeth AH, Jardim LB, Coarelli G, Dankova M, Traschutz A, Tarnutzer AA. Quantitative oculomotor assessment in hereditary ataxia: systematic review and consensus by the Ataxia Global Initiative working group on digital-motor biomarkers. Cerebellum. 2023. https://doi.org/10.1007/s12311-023-01559-9.

Article  PubMed  PubMed Central  Google Scholar 

Group. F-NBW. BEST (Biomarkers, EndpointS, and other Tools) Resource [Internet]. Silver Spring (MD): Food and Drug Administration (US); 2016

Garces P, Antoniades CA, Sobanska A, Kovacs N, Ying SH, Gupta AS, Perlman S, Szmulewicz DJ, Pane C, Nemeth AH, Jardim LB, Coarelli G, Dankova M, Traschutz A, Tarnutzer AA. Quantitative oculomotor assessment in hereditary ataxia: discriminatory power, correlation with severity measures, and recommended parameters for specific genotypes. Cerebellum. 2023. https://doi.org/10.1007/s12311-023-01514-8.

Article  PubMed  PubMed Central  Google Scholar 

Marras C, Lang A, van de Warrenburg BP, Sue CM, Tabrizi SJ, Bertram L, Mercimek-Mahmutoglu S, Ebrahimi-Fakhari D, Warner TT, Durr A, Assmann B, Lohmann K, Kostic V, Klein C. Nomenclature of genetic movement disorders: recommendations of the international Parkinson and movement disorder society task force. Mov Disord. 2016;31:436–57. https://doi.org/10.1002/mds.26527.

Article  PubMed  Google Scholar 

Rossi M, Anheim M, Durr A, Klein C, Koenig M, Synofzik M, Marras C, van de Warrenburg BP, International P, Movement Disorder Society Task Force on C, Nomenclature of Genetic Movement D. The genetic nomenclature of recessive cerebellar ataxias. Mov Disord. 2018;33:1056–76. https://doi.org/10.1002/mds.27415.

Article  PubMed  Google Scholar 

Beaudin M, Matilla-Duenas A, Soong BW, Pedroso JL, Barsottini OG, Mitoma H, Tsuji S, Schmahmann JD, Manto M, Rouleau GA, Klein C, Dupre N. The classification of autosomal recessive cerebellar ataxias: a consensus statement from the Society for Research on the Cerebellum and Ataxias Task Force. Cerebellum. 2019;18:1098–125. https://doi.org/10.1007/s12311-019-01052-2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mariani LL, Rivaud-Pechoux S, Charles P, Ewenczyk C, Meneret A, Monga BB, Fleury MC, Hainque E, Maisonobe T, Degos B, Echaniz-Laguna A, Renaud M, Wirth T, Grabli D, Brice A, Vidailhet M, Stoppa-Lyonnet D, Dubois-d’Enghien C, Le Ber I, Koenig M, Roze E, Tranchant C, Durr A, Gaymard B, Anheim M. Comparing ataxias with oculomotor apraxia: a multimodal study of AOA1, AOA2 and AT focusing on video-oculography and alpha-fetoprotein. Sci Rep. 2017;7: 15284. https://doi.org/10.1038/s41598-017-15127-9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6: e1000100. https://doi.org/10.1371/journal.pmed.1000100.

Article  PubMed  PubMed Central  Google Scholar 

Group F-NBW. BEST (Biomarkers, EndpointS, and other Tools). Silver Spring (MD), USA: Food and Drug Administration (US); 2016

Schober P, Boer C, Schwarte LA. Correlation coefficients: appropriate use and interpretation. Anesth Analg. 2018;126:1763–8. https://doi.org/10.1213/ANE.0000000000002864.

Article  PubMed  Google Scholar 

McLennan YA, Mosconi MW, McKenzie FJ, Famula J, Krawchuk B, Kim K, Clark CJ, Hessl D, Rivera SM, Simon TJ, Tassone F, Hagerman RJ. Prosaccade and antisaccade behavior in fragile X-associated tremor/ataxia syndrome progression. Mov Disord Clin Pract. 2022;9:473–8. https://doi.org/10.1002/mdc3.13449.

Article  PubMed  PubMed Central  Google Scholar 

Wong LM, Goodrich-Hunsaker NJ, McLennan Y, Tassone F, Zhang M, Rivera SM, Simon TJ. Eye movements reveal impaired inhibitory control in adult male fragile X premutation carriers asymptomatic for FXTAS. Neuropsychology. 2014;28:571–84. https://doi.org/10.1037/neu0000066.

Article  PubMed  PubMed Central  Google Scholar 

Fielding-Gebhardt H, Kelly SE, Unruh KE, Schmitt LM, Pulver SL, Khemani P, Mosconi MW. Sensorimotor and inhibitory control in aging FMR1 premutation carriers. Front Hum Neurosci. 2023;17:1271158. https://doi.org/10.3389/fnhum.2023.1271158.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Havla J, Moser M, Sztatecsny C, Lotz-Havla AS, Maier EM, Hizli B, Schinner R, Kümpfel T, Strupp M, Bremova-Ertl T, Schneider SA. Retinal axonal degeneration in Niemann-Pick type C disease. J Neurol. 2020;267:2070–82. https://doi.org/10.1007/s00415-020-09796-2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rodríguez-Labrada R, Vázquez-Mojena Y, Canales-Ochoa N, Medrano-Montero J, Velázquez-Pérez L. Heritability of saccadic eye movements in spinocerebellar ataxia type 2: insights into an endophenotype marker. Cerebellum Ataxias. 2017;4:19. https://doi.org/10.1186/s40673-017-0078-2.

Article  PubMed  PubMed Central  Google Scholar 

Reetz K, Rodríguez-Labrada R, Dogan I, Mirzazade S, Romanzetti S, Schulz JB, Cruz-Rivas EM, Alvarez-Cuesta JA, Aguilera Rodríguez R, Gonzalez Zaldivar Y, Auburger G, Velázquez-Pérez L. Brain atrophy measures in preclinical and manifest spinocerebellar ataxia type 2. Ann Clin Transl Neurol. 2018;5:128–37. https://doi.org/10.1002/acn3.504.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Elyoseph Z, Geisinger D, Zaltzman R, Mintz M, Gordon CR. Horizontal vestibulo-ocular reflex deficit as a biomarker for clinical disease onset, severity, and progression of Machado-Joseph disease. Cerebellum. 2023. https://doi.org/10.1007/s12311-023-01552-2.

Article  PubMed  Google Scholar 

Wu C, Chen DB, Feng L, Zhou XX, Zhang JW, You HJ, Liang XL, Pei Z, Li XH. Oculomotor deficits in spinocerebellar ataxia type 3: potential biomarkers of preclinical detection and disease progression. CNS Neurosci Ther. 2017;23:321–8. https://doi.org/10.1111/cns.12676.

Article  CAS  PubMed  PubMed Central  Google Scholar 

de Oliveira CM, Leotti VB, Bolzan G, Cappelli AH, Rocha AG, Ecco G, Kersting N, Rieck M, Martins AC, Sena LS, Saraiva-Pereira ML, Jardim LB. Pre-ataxic Changes of Clinical Scales and Eye Movement in Machado-Joseph Disease: BIGPRO Study. Movement disorders : official journal of the Movement Disorder Society. 2021. https://doi.org/10.1002/mds.28466.

Article  PubMed  Google Scholar 

Christova P, Anderson JH, Gomez CM. Impaired eye movements in presymptomatic spinocerebellar ataxia type 6. Arch Neurol. 2008;65:530–6. https://doi.org/10.1001/archneur.65.4.530.

Article  PubMed  Google Scholar 

Seifried C, Velázquez-Pérez L, Santos-Falcón N, Abele M, Ziemann U, Almaguer LE, Martínez-Góngora E, Sánchez-Cruz G, Canales N, Pérez-González R, Velázquez-Manresa M, Viebahn B, Stuckrad-Barre S, Klockgether T, Fetter M, Auburger G. Saccade velocity as a surrogate disease marker in spinocerebellar ataxia type 2. Ann N Y Acad Sci. 2005;1039:524–7. https://doi.org/10.1196/annals.1325.059.

Article  CAS  PubMed  Google Scholar 

Rodríguez-Labrada R, Velázquez-Pérez L, Auburger G, Ziemann U, Canales-Ochoa N, Medrano-Montero J, Vázquez-Mojena Y, González-Zaldivar Y. Spinocerebellar ataxia type 2: measures of saccade changes improve power for clinical trials. Mov Disord. 2016;31:570–8. https://doi.org/10.1002/mds.26532.

Article  CAS  PubMed  Google Scholar 

Lee SU, Kim JS, Kim HJ, Choi JY, Park JY, Kim JM, Yang X. Evolution of the vestibular function during head impulses in spinocerebellar ataxia type 6. J Neurol. 2020;267:1672–8. https://doi.org/10.1007/s00415-020-09756-w.

Article  CAS  PubMed  Google Scholar 

Patterson MC, Vecchio D, Prady H, Abel L, Wraith JE. Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study. Lancet Neurol. 2007;6:765–72. https://doi.org/10.1016/S1474-4422(07)70194-1.

Article